We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Cyprium Metals Limited is a gold business based in Australia. Cyprium Metals shares (CYM) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Cyprium Metals has a trailing 12-month revenue of around $100,000. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
ETF investing
Our top pick for
Overall broker
| 52-week range | $0.165 - $0.37 |
|---|---|
| 50-day moving average | $0.2142 |
| 200-day moving average | $0.2524 |
| Target price | N/A |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.056 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$0.2
| 1 week (2021-10-20) | -9.09% |
|---|---|
| 1 month (2021-09-27) | -16.67% |
| 3 months (2021-07-27) | -23.08% |
| 6 months (2021-04-27) | -25.93% |
| 1 year (2020-10-27) | 14.29% |
|---|---|
| 2 years (2019-10-25) | 0.2 |
| 3 years (2018-10-25) | 14.29% |
| 5 years (2016-10-27) | 36.66% |
Valuing Cyprium Metals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Cyprium Metals 's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Cyprium Metals 's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $496,670 (£271,536).
The EBITDA is a measure of a Cyprium Metals 's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $100,000 |
|---|---|
| Gross profit TTM | $100,000 |
| Return on assets TTM | -8.08% |
| Return on equity TTM | -20.82% |
| Profit margin | 0% |
| Book value | 0.183 |
| Market capitalisation | $118.6 million |
TTM: trailing 12 months
We're not expecting Cyprium Metals to pay a dividend over the next 12 months.
Cyprium Metals 's shares were split on a 2:1 basis on 31 May 2018. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Cyprium Metals shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Cyprium Metals shares which in turn could have impacted Cyprium Metals 's share price.
Over the last 12 months, Cyprium Metals 's shares have ranged in value from as little as $0.165 up to $0.37. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Cyprium Metals 's is 0.8723. This would suggest that Cyprium Metals 's shares are less volatile than average (for this exchange).
Cyprium Metals Limited engages in the exploration of copper projects in Australia. It has copper projects in the Murchison region in Western Australian mining jurisdiction, which includes the Cue copper project and the nearby Nanadie Well Copper gold project; and copper projects in the Paterson Province of Western Australia that comprises the Nifty copper mine, the Maroochydore copper project, and the Paterson exploration project. The company is based in Subiaco, Australia.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Shares in the wealth management giant have been largely stable in the last 6 months.
Everything we know about the Judo Capital Holdings IPO, plus information on how to buy in.
Everything we know about the Alloggio Group IPO, plus information on how to buy in.
Everything we know about the Larvotto Resources IPO, plus information on how to buy in.
Everything we know about the Vulcan Steel IPO, plus information on how to buy in.
Everything we know about the Artrya IPO, plus information on how to buy in.
Everything we know about the 8 Au IPO, plus information on how to buy in.
Everything we know about the Radiopharm Theranostics IPO, plus information on how to buy in.
The online retailer’s shares have lost more than half their value in the last 12 months.
